Fusion of Computed Tomography and PROPELLER Diffusion-Weighted Magnetic Resonance Imaging for the Detection and Localization of Middle Ear Cholesteatoma

Authors:

Abstract
Computed tomography (CT) has traditionally been the imaging modality of choice for diagnosis and evaluation of clinically suspected cholesteatoma. Despite its excellent spatial resolution, high sensitivity, and precise delineation of key anatomical landmarks,1 a limitation of CT is its low specificity for differentiating cholesteatoma from other soft tissue (granulation tissue, inflammation, cholesterol granuloma, or fibrosis) or from fluid in the middle ear or mastoid.2 These soft tissues are present in 20% to 30% of previously operated ears, regardless of whether cholesteatoma is present.3 Other studies have shown the sensitivity, specificity, and positive predictive value of CT in diagnosing residual and/or recurrent cholesteatoma to be only 42.9%, 48.3%, and 28.6%, respectively.3,4 As a result, “second-look” surgical exploration remains the benchmark diagnostic modality for residual and/or recurrent cholesteatoma.

This publication has 10 references indexed in Scilit: